BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang C, Zhang J, Ma Y, Wu C, Cui W, Wang L. Histone methyltransferase and drug resistance in cancers. J Exp Clin Cancer Res 2020;39:173. [PMID: 32859239 DOI: 10.1186/s13046-020-01682-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Tavakoli Shirazi P, Eadie LN, Page EC, Heatley SL, Bruning JB, White DL. Constitutive JAK/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemia. Cancer Lett 2021;512:28-37. [PMID: 33971281 DOI: 10.1016/j.canlet.2021.04.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wu Q, Berglund AE, Etame AB. The Impact of Epigenetic Modifications on Adaptive Resistance Evolution in Glioblastoma. Int J Mol Sci 2021;22:8324. [PMID: 34361090 DOI: 10.3390/ijms22158324] [Reference Citation Analysis]
3 Chopra A, Willmore WG, Biggar KK. Insights into a Cancer-Target Demethylase: Substrate Prediction through Systematic Specificity Analysis for KDM3A. Biomolecules 2022;12:641. [DOI: 10.3390/biom12050641] [Reference Citation Analysis]
4 Alghamian Y, Soukkarieh C, Abbady AQ, Murad H. Investigation of role of CpG methylation in some epithelial mesenchymal transition gene in a chemoresistant ovarian cancer cell line. Sci Rep 2022;12:7494. [PMID: 35523936 DOI: 10.1038/s41598-022-11634-6] [Reference Citation Analysis]
5 Reyes DA, Sarría VMS, Salazar-Viedma M, D'Afonseca V. Histone Methyltransferases Useful in Gastric Cancer Research. Cancer Inform 2021;20:11769351211039862. [PMID: 34413625 DOI: 10.1177/11769351211039862] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Chen S, Zhao Y, Liu S, Zhang J, Assaraf YG, Cui W, Wang L. Epigenetic enzyme mutations as mediators of anti-cancer drug resistance. Drug Resistance Updates 2022. [DOI: 10.1016/j.drup.2022.100821] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Aoki Y, Tome Y, Han Q, Yamamoto J, Hamada K, Masaki N, Bouvet M, Nishida K, Hoffman RM. Histone H3 lysine-trimethylation markers are decreased by recombinant methioninase and increased by methotrexate at concentrations which inhibit methionine-addicted osteosarcoma cell proliferation. Biochem Biophys Rep 2021;28:101177. [PMID: 34877414 DOI: 10.1016/j.bbrep.2021.101177] [Reference Citation Analysis]
8 Mandumpala JJ, Baby S, Tom AA, Godugu C, Shankaraiah N. Role of histone demethylases and histone methyltransferases in triple-negative breast cancer: Epigenetic mnemonics. Life Sci 2022;292:120321. [PMID: 35031259 DOI: 10.1016/j.lfs.2022.120321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Yang L, Jin M, Jeong KW. Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers. Biology (Basel) 2021;10:581. [PMID: 34201935 DOI: 10.3390/biology10070581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Xiang X, Zhu J, Dong G, Dong Z. Epigenetic Regulation in Kidney Transplantation. Front Immunol 2022;13:861498. [PMID: 35464484 DOI: 10.3389/fimmu.2022.861498] [Reference Citation Analysis]
11 Wang W, Sun Y, Liu X, Kumar SK, Jin F, Dai Y. Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy. Front Oncol 2022;12:859455. [PMID: 35574302 DOI: 10.3389/fonc.2022.859455] [Reference Citation Analysis]
12 Bashash D, Zandi Z, Kashani B, Pourbagheri-Sigaroodi A, Salari S, Ghaffari SH. Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities. J Cell Physiol 2021. [PMID: 34498289 DOI: 10.1002/jcp.30575] [Reference Citation Analysis]